ç é¢ã«è¡ãåã«ãã©ãã°ã¹ãã¢ãžè¡ã人ãžãè èãå®ãããã«ç¥ã£ãŠãããããåžè²©è¬ãšãµããªãã®éžã³æ¹
ãã¡ãã£ãšé ãçãã
ããªããé¢šéªæ°å³ããã
âãããªãšãã
ããããç
é¢ã«è¡ãã®ã¯é¢åã ãããšã
ãã©ãã°ã¹ãã¢ã§åžè²©è¬ããµããšè²·ã£ãŠæžãŸããŠããŸãããïŒ
ãããã¯ã
ããç¶ããïŒãæ¯ããïŒã®äœã®ããã«ããšã
éæ±ããã¿ãã³å€ããŠã³ã³ãªã©ã®ãµããªã¡ã³ãã
æ¯æè²·ãç¶ããŠããæ¹ã¯ããŸãããïŒ
æ°æã¡ã¯ããããããŸãã
ââã§ãå®ã¯ããã©ãã°ã¹ãã¢ã§äœæ°ãªãéžãã è¬ããå®¶æã®ããã«è²·ã£ãŠãããµããªããããªããå®¶æã®è èãå·ã€ããŠãããããããŸããã
ð± ãã®èšäºãèªãåã«ãç¡æã®2èšäºããèªããšå®å¿ã§ãããªã³ã¯ã貌ã£ãŠãããŸãã®ã§ãã®ãããŠã¿ãŠãã ããã
ããŸãç¥ã£ãŠã»ãããè¡å§ã®è¬ïŒåžè²©ã®çã¿æ¢ããåŒãèµ·ãããäžéã®å±éºããšãã®é²ãæ¹
ãæ°åã®èŠæ¹ããå¥åº·èšºæã®èœãšã穎ããã¯ã¬ã¢ããã³ã¯æ£åžžããä¿¡ããŠã¯ãããªãçç±
åå°ãã§ãããšããã§ããã®èšäºã§ã¯ãå ·äœçã«ã©ã®åžè²©è¬ã»ã©ã®ãµããªã«æ³šæãã¹ãããããè¬å€åž«ããã©ãã°ã¹ãã¢ã§å®éã«ãã§ãã¯ããŠããç®ç·ã§ãäŒãããŸãã
ç
é¢ã¯åŸ
ã¡æéãé·ãã
ç
é¢ã«ãäžè©±ã«ãªããªããŠãããããã«ã
ãŸãã¯ã§ããããšããå¥åº·ç®¡çãå§ãããã
ãµããªã¯ãé£åã ããå®å
šããšæãããã
ã§ãââ
çµè«ããèšããŸãã
æè»œã«è²·ããåžè²©è¬ããäœã«è¯ããã¯ãã®
ãµããªã¡ã³ãã®äžã«ã
匱ã£ãè
èã«åãè¿ãã®ã€ããªããã¡ãŒãžã
äžãããã®ããããŸãã
ç§ã¯è
èç
ã®è¬ç©çæ³ãå°éã«
åŠãã§ããè¬å€åž«ã§ãç
é¢ã«å€åããŠããŸãã
å
¥é¢ããŠããæ£è
ããã®è·ç©ã確èªãããšãã
ãè¬æåž³ã«ã¯èŒã£ãŠããªããå·Ÿçè¢ã®äžèº«ã
âåžè²©è¬ãå¥åº·é£åãè¬ã®ãµããªã®å±±â
ãç®ã«ãããã³ã«ã
ãã€ããšããå Žé¢ããããŸãã
æ£è
ããã¯èªåã®äœã®ããšãèããŠ
éžãã§ããŸããã
ãäœã®ããã«è¯ããšæã£ãŠããã
ãç
é¢ã§åŠæ¹ãããè¬ãšå¥ç©ã ãšæã£ãŠããã
âãã ããã ãã§ãã
ã§ããè
èã¯ãã®åã ããéãã«ã
ã§ã確å®ã«è¿œãè©°ããããŠãããã§ãã
ãã®èšäºã§ã¯ããããªçŸå Žã§ã®å®äœéšãããšã«ã
æå€ãªèœãšã穎ã3ã€ã®ã¯ãŒã¹ãã«
çµã£ãŠè§£èª¬ããŸãã
ãŸãã¯ãäœãå±ãªãããã®å
šäœåããäŒããã
ãã®åŸã«ãããã©ãã°ã¹ãã¢ã®æ£ã®åã§è¿·ããéžã¹ããå
·äœçãªæååã»èŠåãæ¹ã»ä»£æ¿æ¡ããŸãšããŠããŸãã
ð ãã®èšäºã¯ãããªæ¹ã«èªãã§ã»ãã
ã»è èç ïŒCKDïŒãšèšºæãããŠããæ¹ã
ããŸãã¯ãã®ãå®¶æã»ä»è·ããããŠããæ¹
ã»å¥åº·èšºæã§ãeGFRãäœãããè æ©èœã«æ³šæããšèšãããããšãããæ¹
ã»ãåžè²©è¬ããµããªããããªã倧äžå€«ããš
ãããããŸã§æ·±ãèããã«äœ¿ã£ãŠããæ¹
⌠ãã¯ãŒã¹ã1ãïŒãã£ã±ãäžçªæããçã¿æ¢ãïŒNSAIDsïŒãã®éè€
ð¡ ãã®ã»ã¯ã·ã§ã³ã§åããããš
ã»ãã©ãã°ã¹ãã¢ã§æãæè»œã«è²·ããŠãæãè èãå·ããããåžè²©è¬ãšã¯
ã»ãªãNSAIDsãè èã«å±éºãªã®ã
ã»ç æ£ã§ç¹°ãè¿ãèŠãŠãããå±éºãªéè€ãã®ãã¿ãŒã³
ã»ãåŠæ¹è¬ã飲ãã§ããªããã倧äžå€«ããå±éºãªçç±
è èç ã®äººãåžè²©è¬ã§æãé¿ããã¹ããã®ãããã¯çã¿æ¢ãã§ãã
ãããœãã³Sã
ã€ããããã§ã³ã
ããã¡ãªã³ãã¬ãã¢ã
âãã©ãã°ã¹ãã¢ã®æ£ã«åœããåã®ããã«
䞊ãã§ãããããã®è¬ã¯ã
NSAIDsïŒéã¹ããã€ãæ§æççè¬ïŒ ãšåŒã°ããã°ã«ãŒãã«å±ããŠããŸãã
é çãçççãæ¯çãè©ããâŠâŠ
ãšå¹
åºããçã¿ãã«å¹ãããã
æ¥æ¬ã§æããã䜿ãããåžè²©è¬ã®ã²ãšã€ã§ãã
ã§ããè
æ©èœãäœäžããŠããæ¹ã«ãšã£ãŠã
ãã®NSAIDsã¯
ãæè»œã«è²·ããè¬ãã®äžã§æãå±éºãªã°ã«ãŒã
ãšèšã£ãŠãéèšã§ã¯ãããŸããã
ãªãNSAIDsã¯è èã«å±éºãªã®ã
NSAIDsãè
èã®è¡æµãçµã£ãŠããŸã
ã¡ã«ããºã ã«ã€ããŠã¯ã
以åã®èšäºãè
èãå®ãè¬ã®è©±ãã§
詳ãã解説ããŠããŸãã
ãŸã ãèªã¿ã§ãªãæ¹ã¯ãã²ãã¡ãã
ã芧ãã ããã
ç°¡åã«èšããšãNSAIDsã¯è
èã®è¡ç®¡ãåºããŠããããã«å¿
èŠãªç©è³ªïŒããã¹ã¿ã°ã©ã³ãžã³ïŒã®åããéªéããŸãã
å¥åº·ãªè
èã§ããã°å¥ã®ä»çµã¿ã§è£ããŸããã
ãã§ã«æ©èœãèœã¡ãŠããè
èã«ã¯
ãã®äœè£ããããŸããã
è¡æµãæ¥æ¿ã«äœäžãã
æ¥æ§è
é害ïŒAKIïŒãåŒãèµ·ãããŠããŸããªã¹ã¯ããããŸãã
ç æ£ã§äœåºŠãèŠãŠãããå±éºãªéè€ã
ããã§ãçŸå Žã§ããééããã±ãŒã¹ã
ã²ãšã€ãäŒãããŸãã
å
¥é¢ããŠããæ£è
ããã®ãè¬æåž³ã確èªãããšã
䞻治å»ãããã§ã«çã¿æ¢ããåŠæ¹ãããŠããŸãã
ãšãããè·ç©ã®äžãèŠããšã
åžè²©ã®ãããœãã³Sãã€ããããã§ã³ç³»ã®è¬ã
å¥ã«å
¥ã£ãŠãããã§ãã
çç±ãèããšã
決ãŸã£ãŠãããªçããè¿ã£ãŠããŸãã
ãåŠæ¹ãããè¬ã¯æ±ºãŸã£ãæéã«ãã飲ããªããããçããšãã«ãã飲ããããæå ã«çœ®ããŠããã
ãå çã«ããã£ãè¬ãšåžè²©è¬ã¯å¥ç©ã ãšæã£ãŠããã
ãå çã®çã¿æ¢ããå¹ããªããªããŠãç³ãèš³ãªããŠèšããªãã
æ£è
ããã®æ°æã¡ã¯çãã»ã©ããããŸãã
ã§ããè¬å€åž«ã®ç®ããèŠããšã
ããã¯NSAIDsã2çš®é¡åæã«äœ¿ã£ãŠããç¶æ
ã§ãã
è
èãžã®è² æ
ã¯åçŽã«éãªãã
æ¥æ§è
é害ã®ãªã¹ã¯ãè·³ãäžãããŸãã
ãèªåã¯åŠæ¹è¬ã飲ãã§ããªããã倧äžå€«ãã¯æ¬åœã
åŠæ¹è¬ãšã®éè€ããªããã°å®å¿ã
ãšããããã§ããããŸããã
è
æ©èœãäœäžããŠããæ¹ïŒeGFRãäœãæ¹ïŒã¯ã
ããšãNSAIDsã1çš®é¡ã ã䜿ã£ãŠããŠãã
å¥åº·ãªäººãšåãããã«ã¯ä»£è¬ã»ææ³ã§ããŸããã
ããã€ããšåãéããçæéã ããã®ã€ãããã
è
èã«ãšã£ãŠã¯éå°ãªè² è·ã«ãªã£ãŠããããšããããŸãã
ãåžè²©è¬ã ããå®å šãã§ã¯ãªãã
ãè èã匱ã£ãŠãããšãã¯ãçã¿æ¢ãã®åžè²©è¬ã¯ååãšããŠæãåºããªãã
âè¬å€åž«ãšããŠã®ãç§ã®åºæ¬çãªã¹ã¿ã³ã¹ã§ãã
ã§ã¯ãçããšãã¯ã©ãããã°ããã®ãã
ãã®çãã¯ãææéšåã®
ã颚éªè¬ã®æ£ããéžã³æ¹ãã®äžã§è§£èª¬ãã
ã¢ã»ãã¢ãããã§ã³ã®è©±ã«ãã€ãªãããŸãã
ãã²ãã¡ããããããŠãèªã¿ãã ããã
⌠ãã¯ãŒã¹ã2ãïŒæåãèŠèœãšããã¡ãªãç·åæåè¬ïŒé¢šéªè¬ïŒã

è èã«ãã¡ãŒãžãäžããŸã
ð¡ ãã®ã»ã¯ã·ã§ã³ã§åããããš
ã»ç·åæåè¬ã«ã¯NSAIDsãå«ãŸããŠãããã®ãå€ã
ã»ã颚éªè¬ããšãçã¿æ¢ãããå¥ã ã«é£²ããšãNSAIDsãéè€ãããªã¹ã¯ããã
ã»ãEXãããã¬ãã¢ã ããªã©äžäœã¢ãã«ã»ã©èŠæ³šæ
ã»å ·äœçãªå®å šãªéžã³æ¹ã¯ææããŒããž
ã颚éªè¬ã¯çã¿æ¢ããšã¯éããâãã®æã蟌ã¿ãå±éºã§ãã
åžè²©ã®ç·åæåè¬ãæã«åã£ããšãã
ãããã¯é¢šéªãæ²»ãè¬ã ããã
çã¿æ¢ããšã¯å¥ç©ã
ãšæã£ãŠããŸãããïŒ
å®ã¯ãããã
è
èã«ãšã£ãŠèŠãã«ããèœãšã穎ã«ãªã£ãŠããŸãã
颚éªè¬ã®ãäžèº«ããèŠãããšããããŸããïŒ
åžè²©ã®ç·åæåè¬ã¯ã
è€æ°ã®æåã
ã²ãšã€ã®ããã±ãŒãžã«å
¥ã£ãŠããŸãã
éŒ»æ°Žãæ¢ããæåã
ãããæããæåã
ç±ãäžããæåâã
ãããŠãã®ãç±ãäžããã»çã¿ãåãããã
è§£ç±é®çæåãšããŠã
ã€ããããã§ã³ïŒNSAIDsïŒãé
åãããŠãã補åãæ°å€ããããŸãã
ã€ãŸãã
ã颚éªè¬ããšããŠé£²ãã§ããã€ããã§ãã
å®éã«ã¯NSAIDsã飲ãã§ããããšã«ãªããŸãã
ã¯ãŒã¹ã1ã§è§£èª¬ãããªã¹ã¯ã¯ã
颚éªè¬ã§ããŸã£ããåãããã«çºçããŸãã
ããã±ãŒãžãéã£ãŠããæåã¯åã
çŸå Žã§ãšãã«æããšæããã®ãã
æ£è
ããèªèº«ã
ãå¥ã®è¬ã ãã倧äžå€«ããšå€æããŠ
éããŠé£²ãã§ããŸããã¿ãŒã³ã§ãã
ããšãã°ããããã±ãŒã¹ããããŸãã
è æ©èœãäœäžããŠããæ£è ãããã
颚éªãã²ããŠåžè²©ã®ç·åæåè¬ã飲ã¿å§ããã
ã§ãç±ã¯ãªããªãäžãããªãããé ãçãã
ã颚éªè¬ã ãããè¶³ããªãããããšã
å¥ã®åžè²©ã®çã¿æ¢ããèªå·±å€æã§è¿œå ããã
ãæ¬äººã¯ããã ãæ²»ãããšããŠããã ãã§ãã
ã颚éªè¬ããšãçã¿æ¢ããã¯å¥ã®ååã ããã
éããŠãåé¡ãªããšæã£ãŠãããã§ãã
ã§ãããã®2ã€ã®ããã±ãŒãžã®è£åŽãèŠããšã
ã©ã¡ãã«ããã€ããããã§ã³ãã®æåãããã
ãã©ã³ãåãéãã ãã§ã
äžèº«ã®æåãå®å
šã«éè€ããŠããã®ã§ãã
ããã¯ã¯ãŒã¹ã1ã§ç޹ä»ãã
ãåŠæ¹è¬ãšã®éè€ããšåãã§ãã
NSAIDsã2çš®é¡åæã«äœ¿ã£ãŠããç¶æ
ãšãªãã
è
èãžã®è² æ
ã¯äžæ°ã«è·³ãäžãããŸãã
ãå¹ãç®ã®åŒ·ãäžäœã¢ãã«ãã»ã©èŠæ³šæ
åããã©ã³ãã®é¢šéªè¬ã§ãã
ãããEXãããããã¬ãã¢ã ããããMAXã
ãªã©ã
å¹ãç®ã®åŒ·ãã謳ãäžäœã¢ãã«ã»ã©ã
ã€ããããã§ã³ãé
åãããŠãã
åŸåããããŸãã
ãããå¹ãããããš
äžäœã¢ãã«ãéžã¶æ¹ã¯å€ãã§ããã
è
æ©èœãäœäžããŠããæ¹ã«ãšã£ãŠã¯ã
ãããé¿ããã¹ãéžæã«ãªã£ãŠããŸããŸãã
ãããã颚éªã®ãšããäœã飲ãã°ããã®ïŒã
ãã®çãããã¢ã»ãã¢ãããã§ã³ãäž»äœãšãã
補åã®éžã³æ¹ã§ãã
å
·äœçãªèŠåãæ¹ãšååã®æ¢ãæ¹ã¯ã
ææéšåã§è©³ãã解説ããŸãã
⌠ãã¯ãŒã¹ã3ãïŒãå¥åº·ã«è¯ããã¯ããæ¯ã«ãªãããµããªã»æŒ¢æ¹ã
ð¡ ãã®ã»ã¯ã·ã§ã³ã§åããããš
ã»ãé£åã ããå®å šããšããæã蟌ã¿ãæãå±éºãªèœãšã穎
ã»è æ©èœãäœäžããŠãããšãå¥åº·æåããææ³ã§ããªããŽããã«ãªã
ã»å ·äœçã«å±éºãªãµããªã®çš®é¡ãšçç±ã¯ææããŒããž
ãé£åã ããå®å
šããèªç¶ç±æ¥ã ãã倧äžå€«ã
âãã®æã蟌ã¿ããè
èã«ãšã£ãŠæãæ²¹æãªããªãçœ ã§ãã
çã¿æ¢ãã颚éªè¬ã¯ãè¬ãã ããæ°ãã€ãããããšæããŸãã
ã§ããµããªã¡ã³ãã¯ãè¬ã§ã¯ãªããããã
ãªããšãªãå®å¿ããŠé£²ãã§ããŸãã
ãã®å¿ççãªããŒãã«ã®äœããããã
è
èç
ãæã€æ¹ã«ãšã£ãŠ
æå€§ã®å±éºãã€ã³ãã§ãã
ç æ£ã§äœåºŠãé ãæ±ãããå·Ÿçè¢ã®äžèº«ã
å
¥é¢ããŠããæ£è
ããã®è·ç©ã確èªãããšãã
è¬å€åž«ãšããŠå¿
ããã§ãã¯ããã®ã
ããè¬æåž³ã«èŒã£ãŠããªãæã¡èŸŒã¿åãã§ãã
åŠæ¹è¬ã¯ãè¬æåž³ã§ææ¡ã§ããŸãã
ã§ãåžè²©ã®ãµããªã¡ã³ããå¥åº·é£åã¯ã
æ£è
ããèªèº«ããè¬ãããªãããããš
ç³åããªãããšãå€ãã
ãããŠå·Ÿçè¢ãããŒãã®äžããåºãŠããã®ãã
éæ±ã®ç²æ«ããã¿ãã³Cã®å€§å®¹éããã«ããŠã³ã³ã®ã«ãã»ã«ã
ãå»åž«ãé©ãããšæžãããè¬ã®å¥åº·é£åã®å±±ââã
䞻治å»ãšäžç·ã«ãããã¯é£²ã¿ç¶ããŠããããã
äžã€ã²ãšã€ç¢ºèªããäœæ¥ã¯ã
æ£çŽãªãšãã骚ãæããŸãã
ã§ããã以äžã«ã
ããªãå
¥é¢åã«
ããã£ãšæ©ã誰ããæ°ã¥ããªãã£ãã®ãã
ãšããæããæ¯åé ãããããŸãã
ãªããµããªãè èãå£ãã®ã
å¥åº·ãªè
èã¯ã
äœã«ãšã£ãŠäžèŠãªãã®ãå°¿ãšããŠææ³ãã
ããã£ã«ã¿ãŒãã®åœ¹å²ãæã£ãŠããŸãã
ãµããªã¡ã³ãã§æã£ãæåãã
äœã£ãåã¯è
èãéããŠäœã®å€ã«åºãŠãããŸãã
ãšããããeGFRãäœäžããè
èã§ã¯ã
ãã®ãææ³ããåããèœã¡ãŠããŸãã
å¥åº·ãªäººãªãåé¡ãªãå°¿ã§æµããæåãã
è
æ©èœäœäžè
ã®äœå
ã§ã¯åŠçããããã«
èç©ããŠãããŸãã
ãå¥åº·ã«è¯ãæåãã®ã¯ããã
è
èã«ãšã£ãŠã¯ãåŠçããããªããŽããã«ãªã£ãŠããŸãã®ã§ãã

ãå¥åº·ã«è¯ãæåããå±éºã«ãªã£ãŠããŸã
eGFRãšãã®æå³ã«ã€ããŠã¯
以äžã®èšäºã§ãããã解説ããŠããŸãã
ãŸã ãèªã¿ã§ãªãæ¹ã¯ãã²ã芧ãã ããã
ãåŠæ¹è¬ããããŠãµããªã§æ²»ãããã¯æãå±éºãªéžæ
ããã²ãšã€ã
ã©ãããŠãäŒããŠããããããšããããŸãã
ãè¬ã®å¯äœçšãå¿é
ã ããã
ã代ããã«ãµããªã§æ²»ãããã
âããããæ°æã¡ã¯ã
決ããŠçãããã®ã§ã¯ãããŸããã
é·æéè¬ã飲ã¿ç¶ããããšãžã®äžå®ã¯ã
æ£è
ããããæ¥ã
èã声ã®ã²ãšã€ã§ãã
ãã ãåŠæ¹è¬ãèªå·±å€æã§ãããããšã ãã¯ã
ã©ããèžã¿ãšã©ãŸã£ãŠãã ããã
è
èç
ã®æ²»çè¬ã®äžã«ã¯ã
è
èããã以äžå·ããªãããã«æ¬ ãããªããã®ãå«ãŸããŠããŸãã
ãããçªç¶äžæããŠ
ãµããªã«åãæ¿ããŠããŸããšã
æ°ã¥ããªããã¡ã«ç
æ°ãé²è¡ããŠããŸã
ããšããããŸãã
ãµããªã¯ãããŸã§ãè£å©ãã§ããã
åŠæ¹è¬ã®ä»£ããã«ã¯ãªããŸããã
ãä»é£²ãã§ããè¬ãå€ãããã
ããµããªã远å ãããããšæã£ããšãã¯ã
ãŸã䞻治å»ãè¬å€åž«ã«
äžèšçžè«ããŠã¿ãŠãã ããã
ãã£ãšäžç·ã«èããŠãããŸãã
â ïž ããããå ·äœçã«ã©ã®ãµããªãå±ãªãã®ïŒã
éæ±ããã¿ãã³Cããã¿ãã³DããŠã³ã³ãã¯ã©ã³ããªãŒ
âŠâŠãå¥åº·ã«è¯ãããšããŠåºã飲ãŸããŠãããµããªã®äžã«ã
è æ©èœäœäžè ã«ã¯æ·±å»ãªãªã¹ã¯ããããããã®ãè€æ°ãããŸãã
ããããã®å±éºãªçç±ã»ã¡ã«ããºã ã»æ³šæãã¹ãeGFRã®ç®å®ã¯ãææããŒãã§è©³ãã解説ããŸãã
⌠ãããŸã§ã®ãŸãšãïŒè èã¯ãéãã«å£ããŠãã
ãããŸã§3ã€ã®ã¯ãŒã¹ããèŠãŠããŸããã
æ¹ããŠæŽçããŸãã
ðŽ ã¯ãŒã¹ã1ïŒçã¿æ¢ãïŒNSAIDsïŒã®éè€
ãããœãã³Sã»ã€ããããã§ã³ç³»ã¯ã
è
èã®è¡æµãäœäžãããã
åŠæ¹è¬ãšã®éè€ã¯ãšãã«å±éºã
ðŽ ã¯ãŒã¹ã2ïŒç·åæåè¬ïŒé¢šéªè¬ïŒã®æåèŠèœãšã
ãEXãããã¬ãã¢ã ããªã©
äžäœã¢ãã«ã®é¢šéªè¬ã«ã¯ã
NSAIDsãå«ãŸããŠãããã®ãå€ãã
ã颚éªè¬ïŒçã¿æ¢ããã®éè€ã«èŠæ³šæã
ðŽ ã¯ãŒã¹ã3ïŒãäœã«è¯ãããµããªã»å¥åº·é£å
è
æ©èœãäœäžããäœã§ã¯ã
å¥åº·æåãææ³ã§ããã«èç©ããã
åŠæ¹è¬ãèªå·±å€æã§ãããŠ
ãµããªã«åãæ¿ããã®ã¯æãé¿ããŠã»ããè¡åã
ãããã«å
±éããŠããã®ã¯ã
ãæªæã®ããéžæãã§ã¯ãªãã
ãåæã®æã蟌ã¿ãããèµ·ããŠãã
ãšããç¹ã§ãã
ãåžè²©è¬ã ãã倧äžå€«ã
ãé£åã ããå®å¿ã
ãäœã®ããã«è¯ãããšãããŠããã
âãã®æ°æã¡ã¯æ¬ç©ã§ãã
ã§ãè
èã¯ã
ãã¡ãŒãžãåããŠãçã¿ã§æããŠãããŸããã
æ°ã¥ãããšãã«ã¯ã
åãè¿ãã®ã€ããªã段éãŸã§
é²ãã§ããããšããããŸãã
ã ããããã
ãç¥ã£ãŠãããã©ãããã
è
èãå®ãæå€§ã®æŠåšã«ãªããŸãã
ãããŸã§ã¯ãäœãå±ãªãããã®å
šäœåã
ãäŒãããŸããã
ã§ããå€ãã®æ¹ãæ¬åœã«ç¥ãããã®ã¯
ãããããå
·äœçã«äœãéžã¹ã°ããã®ãã
ã§ã¯ãªãã§ããããã
ããããå
ã§ã¯ã
è
èç
ã®è¬ç©çæ³ãå°éã«åŠãã§ãã
è¬å€åž«ã®èŠç¹ããã
ãã©ãã°ã¹ãã¢ã®æ£ã®åã§ãã®ãŸãŸäœ¿ããç¥èã
å
·äœçã«ãŸãšããŠããŸãã
ð ææéšåã®å 容
â 颚éªè¬ã®ãå®å šãªéžã³æ¹ã
ââæå衚ã®ã©ããèŠãããã¢ã»ãã¢ãããã§ã³ãšã¯äœã
â è èã«å±éºãªãµããªå®åãªã¹ã
ââéæ±ã»ãã¿ãã³Cã»ãã¿ãã³Dã»ãŠã³ã³ã»ã¯ã©ã³ããªãŒã»ææ©ã²ã«ãããŠã ã»ãããªãå±éºãªã®ããã¡ã«ããºã ãšãšãã«è§£èª¬
â çŽ éº¹åé¡ãæããŠããããæåè¡šã«æžããŠããªããªã¹ã¯ã
â ãã©ãã°ã¹ãã¢ã§ä»æ¥ãã䜿ãããè èãå®ã3ã€ã®ç¿æ £ã
â è¬å€åž«ã»ç»é²è²©å£²è ãžã®ãæ£ããçžè«ã®ä»æ¹ã
ââeGFRãäŒããã ãã§å¯Ÿå¿ãå€ããçç±
ãç¥ã£ãŠããã°é²ãããâãããªåŸæãã
ã²ãšãã§ãå°ãªãããããšæã£ãŠ
ãã®èšäºãæžããŠããŸãã
倧åãªèªåã®è
èã
ãããŠå®¶æã®è
èãå®ãããã«ã
ãã²ããããå
ããèªã¿ããã ãããš
å¬ããã§ãã
ããããå ã¯
Â¥ 500
ãããããã°å¿æŽãé¡ãããŸãïŒããã ãããããã¯ãªãããã³Cã®è³Œå ¥è²»ãšããŠã¢ãããŒã·ã§ã³ãšæŽ»åã¢ããã«äœ¿ãããŠããã ããŸãâš
